Small-Molecule APIs

Dec 02, 2018
Pharmaceutical Technology
Antibody-based drugs offer new mechanisms of action and greater specificity.
Nov 02, 2018
Pharmaceutical Technology
Demand for highly potent APIs continues to rise.
Oct 02, 2018
Pharmaceutical Technology
Integration of new modeling and analytical tools with flow chemistry are notable trends.
Sep 18, 2018
By Pharmaceutical Technology Editors
The $425-million acquisition adds formulation development and finished dosage manufacturing capabilities to Cambrex’s existing global API manufacturing network.
Sep 04, 2018
By Pharmaceutical Technology Editors
As it investigates the root cause of an impurity discovered in valsartan, FDA extends its studies to APIs with similar synthesis processes.
Sep 02, 2018
Pharmaceutical Technology
Existing software tools cannot take into account the complexity of disease.
Aug 02, 2018
Pharmaceutical Technology
Low-temperature chemistry enables performance of more challenging and selective chemistry.
Jul 23, 2018
By Pharmaceutical Technology Editors
The acquisition will place Cambrex into the finished dosage form CDMO market.
Jun 02, 2018
Pharmaceutical Technology
From separation systems to reactor technology, new tools are increasing the feasibility of continuous API production.
May 16, 2018
By Pharmaceutical Technology Editors
Cambrex Corporation has announced facility, equipment, and instrument upgrades at its High Point, NC facility and updated progress on expansions in Cedar City, IA.
native1_300x100
lorem ipsum